Drug intelligence / Profile preview

monospecific integrin αv antibody

Development stage
Preclinical
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

A monospecific integrin αv antibody is a monoclonal antibody designed to bind specifically to the αv (alpha-v) subunit of integrin receptors. Integrin αv is a component of several heterodimeric receptors (including αvβ1, αvβ3, αvβ5, αvβ6, and αvβ8) that play critical roles in cell adhesion, migration, and survival signaling. In oncology research, particularly in prostate cancer, αv-containing integrins are associated with tumor progression, chemotaxis, and immune evasion. These antibodies are often utilized in preclinical studies to investigate the inhibition of pathological signaling pathways such as c-myc/E2F and TGF-β. While monospecific αv antibodies have shown some efficacy in controlling tumor growth, they are frequently compared to bispecific antibodies (e.g., targeting both αv and α5β1) which may offer superior therapeutic outcomes by inducing target internalization and lysosomal degradation.

Other names
monospecific integrin αv antibodyanti-integrin αv antibodyanti-αv antibody
02

Targets

ITGAV (Integrin αV)

Beyond the preview

Go deeper on monospecific integrin αv antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on monospecific integrin αv antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call